Delta Phenomics engages in collaborative partnerships with pharmaceutical, nutrition and biotechnology companies as well as with universities and research institutes. Projects can include development and validation of novel behavioral test paradigms, phenotyping of mouse or rat mutants, screening for identification of new lead compounds for diseases, and related drug and target discovery work. If you have a specific project idea, please contact us.